207
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Association of Mitral Regurgitation with Postoperative Atrial Fibrillation in Critically Ill Noncardiac Surgery Patients: A Prospective Cohort Study

, , , ORCID Icon, &
Pages 769-783 | Received 03 Dec 2022, Accepted 22 Feb 2023, Published online: 28 Feb 2023

References

  • Bedford JP, Ferrando-Vivas P, Redfern O, et al. New-onset atrial fibrillation in intensive care: epidemiology and outcomes. Eur Heart J Acute Cardiovasc Care. 2022;11(8):620–628. doi:10.1093/ehjacc/zuac080
  • Chean CS, McAuley D, Gordon A, Welters ID. Current practice in the management of new-onset atrial fibrillation in critically ill patients: a UK-wide survey. PeerJ. 2017;5:e3716. doi:10.7717/peerj.3716
  • Carrera P, Thongprayoon C, Cheungpasitporn W, Iyer VN, Moua T. Epidemiology and outcome of new-onset atrial fibrillation in the medical intensive care unit. J Crit Care. 2016;36:102–106. doi:10.1016/j.jcrc.2016.06.032
  • Chen AY, Sokol SS, Kress JP, Lat I. New-onset atrial fibrillation is an independent predictor of mortality in medical intensive care unit patients. Ann Pharmacother. 2015;49(5):523–527. doi:10.1177/1060028015574726
  • Knotzer H, Mayr A, Ulmer H, et al. Tachyarrhythmias in a surgical intensive care unit: a case-controlled epidemiologic study. Inten Care Medi. 2000;26(7):908–914. doi:10.1007/s001340051280
  • Schmitt J, Duray G, Gersh BJ, Hohnloser SH. Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications. Eur Heart J. 2009;30(9):1038–1045. doi:10.1093/eurheartj/ehn579
  • Aronson D, Boulos M, Suleiman A, et al. Relation of C-reactive protein and new-onset atrial fibrillation in patients with acute myocardial infarction. Am J Cardiol. 2007;100(5):753–757. doi:10.1016/j.amjcard.2007.04.014
  • Maesen B, Nijs J, Maessen J, et al. Post-operative atrial fibrillation: a maze of mechanisms. Europace. 2012;14(2):159–174. doi:10.1093/europace/eur208
  • Nardi F, Diena M, Caimmi PP, et al. Relationship between left atrial volume and atrial fibrillation following coronary artery bypass grafting. J Card Surg. 2012;27(1):128–135. doi:10.1111/j.1540-8191.2011.01373.x
  • Polanczyk CA, Goldman L, Marcantonio ER, et al. Supraventricular arrhythmia in patients having noncardiac surgery: clinical correlates and effect on length of stay. Ann Intern Med. 1998;129(4):279–285. doi:10.7326/0003-4819-129-4-199808150-00003
  • Ravelli F, Allessie M. Effects of atrial dilatation on refractory period and vulnerability to atrial fibrillation in the isolated Langendorff-perfused rabbit heart. Circulation. 1997;96(5):1686–1695. doi:10.1161/01.cir.96.5.1686
  • Bahouth F, Mutlak D, Furman M, et al. Relationship of functional mitral regurgitation to new-onset atrial fibrillation in acute myocardial infarction. Heart. 2010;96(9):683–688. doi:10.1136/hrt.2009.183822
  • Fan Y, Wan S, Wong RH-L, Lee AP-W. Atrial functional mitral regurgitation: mechanisms and surgical implications. Asian Cardiovasc Thorac Ann. 2020;28(7):421–426. doi:10.1177/0218492320941388
  • Levine RA, Schwammenthal E. Ischemic mitral regurgitation on the threshold of a solution, from paradoxes to unifying concepts. Circulation. 2005;112(5):745–758. doi:10.1161/CIRCULATIONAHA.104.486720
  • Ruaengsri C, Schill MR, Lancaster TS, et al. The hemodynamic and atrial electrophysiologic consequences of chronic left atrial volume overload in a controllable canine model. J Thorac Cardiovasc Surg. 2018;156(5):1871–1879. doi:10.1016/j.jtcvs.2018.05.078
  • Nakamura K, Takagi T, Kogame N, et al. Impact of atrial mitral and tricuspid regurgitation on atrial fibrillation recurrence after ablation. J Electrocardiol. 2021;66:114–121. doi:10.1016/j.jelectrocard.2021.04.005
  • Gertz ZM, Raina A, Mountantonakis SE, et al. The impact of mitral regurgitation on patients undergoing catheter ablation of atrial fibrillation. Europace. 2011;13(8):1127–1132. doi:10.1093/europace/eur098
  • Arora S, Brown ZD, Sivaraj K, et al. The relationship between atrial fibrillation, mitral regurgitation, and heart failure subtype: the ARIC study. J Card Fail. 2022;28(6):883–892. doi:10.1016/j.cardfail.2021.10.015
  • Almassi GH, Schowalter T, Nicolosi AC, et al. Atrial fibrillation after cardiac surgery, a major morbid event? Ann Surg. 1997;226(4):501–513. doi:10.1097/00000658-199710000-00011
  • Hu W-S, Lin C-L. Prediction of new-onset atrial fibrillation for general population in Asia: a comparison of C2HEST and HATCH scores. Int J Cardiol. 2020;313:60–63. doi:10.1016/j.ijcard.2020.03.036
  • Burgos LM, Ramirez AG, Seoane L, et al. New combined risk score to predict atrial fibrillation after cardiac surgery: COM-AF. Ann Cardiac Anaesth. 2021;24(4):458–463. doi:10.4103/aca.ACA_34_20
  • Stronati G, Mondelli C, Urbinati A, et al. Derivation and validation of a clinical score for predicting postoperative atrial fibrillation in noncardiac elective surgery (the HART score). Am J Cardiol. 2022;170:56–62. doi:10.1016/j.amjcard.2022.01.020
  • Li Y-G, Bisson A, Bodin A, et al. C 2 HEST score and prediction of incident atrial fibrillation in poststroke patients: a French nationwide study. J Am Heart Assoc. 2019;8(13):e012546. doi:10.1161/JAHA.119.012546
  • Chua S-K, Shyu K-G, Lu M-J, et al. Clinical utility of CHADS2 and CHA2DS2-VASc scoring systems for predicting postoperative atrial fibrillation after cardiac surgery. J Thorac Cardiovasc Surg. 2013;146(4):919–926 e1. doi:10.1016/j.jtcvs.2013.03.040
  • von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet. 2007;370(9596):1453–1457. doi:10.1016/S0140-6736(07)61602-X
  • María Burgos L, Gil RA, Brito VG, et al. Development and validation of a simple clinical risk prediction model for new-onset postoperative atrial fibrillation after cardiac surgery: nopaf score. J Atr Fibrillation. 2020;13(2):2249. doi:10.4022/jafib.2249
  • Conen D, Alonso-Coello P, Douketis J, et al. Risk of stroke and other adverse outcomes in patients with perioperative atrial fibrillation 1 year after non-cardiac surgery. Eur Heart J. 2020;41(5):645–651. doi:10.1093/eurheartj/ehz431
  • Fernando SM, Mathew R, Hibbert B, et al. New-onset atrial fibrillation and associated outcomes and resource use among critically ill adults—a multicenter retrospective cohort study. Crit Care. 2020;24(1):15. doi:10.1186/s13054-020-2730-0
  • Higuchi S, Kabeya Y, Matsushita K, et al. Incidence and complications of perioperative atrial fibrillation after non-cardiac surgery for malignancy. PLoS One. 2019;14(5):e0216239. doi:10.1371/journal.pone.0216239
  • Zoghbi WA, Adams D, Bonow RO, et al. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr. 2017;30(4):303–371. doi:10.1016/j.echo.2017.01.007
  • Rudski LG, Lai WW, Afilalo J, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr. 2010;23(7):685–688. doi:10.1016/j.echo.2010.05.010
  • Lip GY, Lane DA. Modern management of atrial fibrillation requires initial identification of “low-risk” patients using the CHA2DS2-VASc score, and not focusing on “high-risk” prediction. Circ J. 2014;78(8):1843–1845. doi:10.1253/circj.cj-14-0584
  • Han J, Li G, Zhang D, Wang X, Guo X. Predicting late recurrence of atrial fibrillation after radiofrequency ablation in patients with atrial fibrillation: comparison of C2HEST and HATCH Scores. Front Cardiovasc Med. 2022;9:907817. doi:10.3389/fcvm.2022.907817
  • de Vos CB, Pisters R, Nieuwlaat R, et al. Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis. J Am Coll Cardiol. 2010;55(8):725–731. doi:10.1016/j.jacc.2009.11.040
  • Greenland S, Pearl J, Robins JM. Causal diagrams for epidemiologic research. Epidemiology. 1999;10(1):37–48. doi:10.1097/00001648-199901000-00008
  • Ananth CV, Schisterman EF. Confounding, causality, and confusion: the role of intermediate variables in interpreting observational studies in obstetrics. Am J Obstet Gynecol. 2017;217(2):167–175. doi:10.1016/j.ajog.2017.04.016
  • Sobolev B, Guy P, Sheehan KJ, et al. Mortality effects of timing alternatives for Hip fracture surgery. CMAJ. 2018;190(31):E923–E932. doi:10.1503/cmaj.171512
  • DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837–845. doi:10.2307/2531595
  • Glassford NJ, Schneider AG, Xu S, et al. The nature and discriminatory value of urinary neutrophil gelatinase-associated lipocalin in critically ill patients at risk of acute kidney injury. Inten Care Med. 2013;39(10):1714–1724. doi:10.1007/s00134-013-3040-7
  • Pencina MJ, D’Agostino RB Sr., D’Agostino RB Jr., Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27(2):157–212. doi:10.1002/sim.2929
  • Orhan AL, Çınar T, Hayıroğlu Mİ, et al. Atrial fibrillation as a preoperative risk factor predicts long-term mortality in elderly patients without heart failure and undergoing Hip fracture surgery. Rev Assoc Med Bras. 2021;67(11):1633–1638. doi:10.1590/1806-9282.20210686
  • Çiçek V, Cinar T, Hayiroglu MI, et al. Preoperative cardiac risk factors associated with in-hospital mortality in elderly patients without heart failure undergoing Hip fracture surgery: a single-centre study. Postgrad Med J. 2021;97(1153):701–705. doi:10.1136/postgradmedj-2020-138679
  • AlTurki A, Marafi M, Proietti R, et al. Major adverse cardiovascular events associated with postoperative atrial fibrillation after noncardiac surgery, a systematic review and meta-analysis. Circ Arrhythm Electrophysiol. 2020;13(1):e007437. doi:10.1161/CIRCEP.119.007437
  • Kanji S, Williamson DR, Yaghchi BM, Albert M, McIntyre L; Canadian Critical Care Trials G. Epidemiology and management of atrial fibrillation in medical and noncardiac surgical adult intensive care unit patients. J Crit Care. 2012;27(3):326e1–8. doi:10.1016/j.jcrc.2011.10.011
  • Lopes LA, Agrawal DK. Post-operative atrial fibrillation: current treatments and etiologies for a persistent surgical complication. J Surg Res. 2022;5(1):159–172. doi:10.26502/jsr.10020209
  • Smith HA, Kanji S, Tran DTT, et al. Prophylaxis for patients at Risk to Eliminate Post-operative Atrial Fibrillation (PREP-AF trial): a protocol for a feasibility randomized controlled study. Trials. 2021;22(1):384. doi:10.1186/s13063-021-05318-1
  • Douedi S, Douedi H. Mitral regurgitation. In: StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2022, StatPearls Publishing LLC.; 2022.
  • Gomes NFA, Silva VR, Levine RA, et al. Progression of mitral regurgitation in rheumatic valve disease: role of left atrial remodeling. Front Cardiovasc Med. 2022;9:862382. doi:10.3389/fcvm.2022.862382
  • Qiao Y, Wu L, Hou B, et al. Functional mitral regurgitation, predictor for atrial substrate remodeling and poor ablation outcome in paroxysmal atrial fibrillation. Medicine. 2016;95(30):e4333. doi:10.1097/MD.0000000000004333
  • Abhayaratna WP, Seward JB, Appleton CP, et al. Left atrial size, physiologic determinants and clinical applications. J Am Coll Cardiol. 2006;47(12):2357–2363. doi:10.1016/j.jacc.2006.02.048
  • Thomas L, Abhayaratna WP. Left atrial reverse remodeling, mechanisms, evaluation, and clinical significance. JACC Cardiovasc Imaging. 2017;10(1):65–77. doi:10.1016/j.jcmg.2016.11.003
  • Maiello M, Sharma RK, Matteo CM, Reddy HK, Palmiero P. Differential left atrial remodeling in LV diastolic dysfunction and mitral regurgitation. Echocardiography. 2009;26(7):772–778. doi:10.1111/j.1540-8175.2008.00889.x
  • Simmers D, Potgieter D, Ryan L, Fahrner R, Rodseth RN. The use of preoperative B-type natriuretic peptide as a predictor of atrial fibrillation after thoracic surgery: systematic review and meta-analysis. J Cardiothorac Vasc Anesth. 2015;29(2):389–395. doi:10.1053/j.jvca.2014.05.015
  • Zhao B-C, Huang T-Y, Deng Q-W, et al. Prophylaxis against atrial fibrillation after general thoracic surgery, trial sequential analysis and network meta-analysis. Chest. 2017;151(1):149–159. doi:10.1016/j.chest.2016.08.1476
  • Manfrini O, Cenko E, Ricci B, Bugiardini R. Post cardiovascular surgery atrial fibrillation. biomarkers determining prognosis. Curr Med Chem. 2019;26(5):916–924. doi:10.2174/0929867324666170727104930
  • Ishibashi H, Wakejima R, Asakawa A, et al. Postoperative atrial fibrillation in lung cancer lobectomy—analysis of risk factors and prognosis. World J Surg. 2020;44(11):3952–3959. doi:10.1007/s00268-020-05694-w
  • Hayıroğlu Mİ, Çınar T, Selçuk M, et al. The significance of the morphology-voltage-P-wave duration (MVP) ECG score for prediction of in-hospital and long-term atrial fibrillation in ischemic stroke. J Electrocardiol. 2021;69:44–50. doi:10.1016/j.jelectrocard.2021.09.006
  • Çinar T, Hayiroğlu Mİ, Selçuk M, et al. Evaluation of electrocardiographic P wave parameters in predicting long-term atrial fibrillation in patients with acute ischemic stroke. Arq Neuropsiquiatr. 2022;80(09):877–884. doi:10.1055/s-0042-1755322
  • Lee CT, Strauss DM, Stone LE, Stoltzfus JC, Puc MM, Burfeind WR. Preoperative CHA2DS2-VASc score predicts postoperative atrial fibrillation after lobectomy. Thorac Cardiovasc Surg. 2019;67(02):125–130. doi:10.1055/s-0038-1675638
  • Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (writing committee to revise the 2001 guidelines for the management of patients with atrial fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006;114(7):e257–354. doi:10.1161/CIRCULATIONAHA.106.177292
  • You JJ, Singer DE, Howard PA, et al. Antithrombotic therapy for atrial fibrillation, antithrombotic therapy and prevention of thrombosis, 9th ed, American college of chest physicians evidence-based clinical practice guidelines. Chest. 2012;141(2):e531S–e575S. doi:10.1378/chest.11-2304
  • Lip GYH, Nieuwlaat R, Pisters R, Lane DA, Crijns HJGM. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach, the euro heart survey on atrial fibrillation. Chest. 2010;137(2):263–272. doi:10.1378/chest.09-1584
  • Hu W-S, Lin C-L. Comparison of CHA2DS2-VASc and C2HEST scores for predicting the incidence of atrial fibrillation among patients with end-stage renal disease. Perfusion. 2020;35(8):842–846. doi:10.1177/0267659120930931
  • Tischer TS, Schneider R, Lauschke J, Diedrich D, Kundt G, Bansch D. Prävalenz von Vorhofflimmern und der HATCH-Score. Herz. 2015;40(5):803–808. doi:10.1007/s00059-015-4305-4
  • Emren V, Aldemir M, Duygu H, et al. Usefulness of HATCH score as a predictor of atrial fibrillation after coronary artery bypass graft. Kardiol Pol. 2016;74(8):749–753. doi:10.5603/KP.a2016.0045
  • Selvi M, Gungor H, Zencir C, et al. A new predictor of atrial fibrillation after coronary artery bypass graft surgery: HATCH score. J Investig Med. 2018;66(3):648–652. doi:10.1136/jim-2017-000525
  • Kristensen SD, Knuuti J. New ESC/ESA guidelines on non-cardiac surgery: cardiovascular assessment and management. Eur Heart J. 2014;35(35):2344–2345. doi:10.1093/eurheartj/ehu285